Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Zhu

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Organic & Biomolecular Chemistry|March 25, 2025
A β-hairpin peptide derived from Aβ forms different oligomers in the crystal state and in aqueous solutionJason Zhu, Adam G Kreutzer, Zhiwei Liu, et al.
Journal for Immunotherapy of Cancer|January 26, 2018
Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyondJason Zhu, Andrew J Armstrong, Terence W Friedlander, et al.
Human Pathology|October 30, 2020
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneityClaud M Grigg, Chad Livasy, Jiaxian He, et al.
Applied Physics Reviews|December 5, 2022
Advanced thermal sensing techniques for characterizing the physical properties of skinSurabhi R Madhvapathy, Hany M Arafa, Manish Patel, et al.
Protein Science : a Publication of the Protein Society|June 23, 2025
Mini-αA-crystallin protects a client lens protein from catastrophic aggregation due to heat stressCollin Sroge, Jaewon Suk, Jason Zhu, et al.
Molecular and Clinical Oncology|April 25, 2022
Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancerEarle F Burgess, Chad Livasy, Sally Trufan, et al.
JCO Precision Oncology|December 7, 2023
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate CancerLandon C Brown, Jason Zhu, Elizabeth Mauer, et al.
Clinical Genitourinary Cancer|March 13, 2019
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell CarcinomaMatthew K Labriola, Kristen A Batich, Jason Zhu, et al.
European Urology Open Science|November 21, 2025
Circulating Tumor Cells and Clinical Outcomes in Men with Metastatic Castration-sensitive Prostate Cancer Treated with Enzalutamide and Docetaxel: An Analysis of the ENZADA TrialLandon C Brown, Danielle Boselli, James T Symanowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with <sup>131</sup>I-MIBGAri Kane, Matthew P Thorpe, Michael A Morse, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Organic & Biomolecular Chemistry|March 25, 2025
A β-hairpin peptide derived from Aβ forms different oligomers in the crystal state and in aqueous solutionJason Zhu, Adam G Kreutzer, Zhiwei Liu, et al.
Journal for Immunotherapy of Cancer|January 26, 2018
Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyondJason Zhu, Andrew J Armstrong, Terence W Friedlander, et al.
Human Pathology|October 30, 2020
Human epidermal growth factor receptor 2 overexpression is frequently discordant between primary and metastatic urothelial carcinoma and is associated with intratumoral human epidermal growth factor receptor 2 heterogeneityClaud M Grigg, Chad Livasy, Jiaxian He, et al.
Applied Physics Reviews|December 5, 2022
Advanced thermal sensing techniques for characterizing the physical properties of skinSurabhi R Madhvapathy, Hany M Arafa, Manish Patel, et al.
Protein Science : a Publication of the Protein Society|June 23, 2025
Mini-αA-crystallin protects a client lens protein from catastrophic aggregation due to heat stressCollin Sroge, Jaewon Suk, Jason Zhu, et al.
Molecular and Clinical Oncology|April 25, 2022
Clinical outcomes associated with expression of aurora kinase and p53 family members in muscle-invasive bladder cancerEarle F Burgess, Chad Livasy, Sally Trufan, et al.
JCO Precision Oncology|December 7, 2023
RNA-Based Homologous Recombination Deficiency Signature Detects Homologous Recombination Deficiency-RNA+ Patients With and Without Homologous Recombination Repair Gene Pathogenic Alterations in Men With Prostate CancerLandon C Brown, Jason Zhu, Elizabeth Mauer, et al.
Clinical Genitourinary Cancer|March 13, 2019
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell CarcinomaMatthew K Labriola, Kristen A Batich, Jason Zhu, et al.
European Urology Open Science|November 21, 2025
Circulating Tumor Cells and Clinical Outcomes in Men with Metastatic Castration-sensitive Prostate Cancer Treated with Enzalutamide and Docetaxel: An Analysis of the ENZADA TrialLandon C Brown, Danielle Boselli, James T Symanowski, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 20, 2018
Predictors of Survival in 211 Patients with Stage IV Pulmonary and Gastroenteropancreatic MIBG-Positive Neuroendocrine Tumors Treated with <sup>131</sup>I-MIBGAri Kane, Matthew P Thorpe, Michael A Morse, et al.
Pageof 7